About
WHAT WE DO
AND WHY WE ARE DIFFERENT
The network of colleagues who make up this foundation are committed to reading and researching all published information on cancer and autoimmune diseases. We contact scientists and physicians all over the world to learn at first hand from these eminent colleagues in hospitals, universities and laboratories.
Our foundation finds treatments from integrative, complementary and conventional medicine. We investigate and combine support therapies to enhance efficacy and decrease side effects for faster, safer and more comfortable treatment in many different diseases.
SUCESSFULLY TREATED DISEASES
Autoimmune diseases including Rheumatoid Arthritis, Graves’ Disease, Hashimoto’ Syndromes, Ulcerative Colitis, Morbus Crohn, Borreliosis/Lyme Disease.
Cancers including Gastrointestinal, Thyroid, Pancreas, Breast cancer with brain metastases, Cervical cancers, Lymphoma, Leukemia and many others.
Viral Diseases including Mononucleosis (EBV) cured in 24-48 hours. Coxsackie B virus, Herpes, HIV, and upper respiratory viruses.
RESEARCH
The newest research in cancer indicates involvement of bacteria and parasites including Chlamydia, borrellia and mycoplasm. In tumor cells the acidic conditions cause pathogenic changes in normally non-pathogenic bacteria allowing them to release tumor growth factors as well as effecting the immune system.
Some of these bacteria and parasites appear to be pleomorphic, living inside cells including leukocytes, lymphocytes and red blood cells(erythrocytes). We are presently investigating identification of these pathogens and methods for their eradication. This work is being carried out in England and the USA and may lead to many exciting and effective new treatments for cancer.
WHAT ARE WE OFFERING YOU?
We are preparing a book for patients who have cancer to inform them which nutrients and diet are safest and best and what should they avoid, so that they have the best response to all treatments.
Dana Flavin-König M.D.
Dr. Dana F. Flavin-Koenig has studied medicine and science internationally for the past 30 years. Her extensive background in Chemistry, Biochemistry, Pharmacology, Nutrient Biochemistry and Medicine has allowed her to find new ways of enhancing patients’ responses to all treatments. Many new treatments were designed specifically for patients who had little improvement from classical pharmacological agents.
Many of her support measures are nutrients and diets that allow patients to remain in remission and live normal symptom-free lives.
Dr. Flavin-Koenig began her extensive research on the Molecular Biology of Cancer in 1979 when she was appointed Science Assistant to the Associate Bureau Director for Toxicology at the Food and Drug Administration in Washington, D.C., USA.
She developed what she calls “Target Therapy”, directed to specific negative intracellular changes in tumors and in cancer. This extensive work resulted in the development of nutrient support measures and therapies in many illnesses including Autoimmune Diseases and cancer.
Download Dr. Flavin-Koenig’s Curriculum Vitae (.pdf)
Colleagues and Medical advisory Board:
Dr. Massimo Bonucci, Rome Italy, Oncologist
Dr. Aldo Mancini Naples, Italy, Oncology
Dr. Ilse Triebnig, Lenz Austria, Oncology and surgery
Dr. Ursula Jacobs, Tegernsee, Germany, Oncology
Dr. Chen Haohui, Bejiing, China, Internal Medicine, Oncology
Dr. Noel Campbell, Australia, Med Dent Oncology
Professor Scheidl, Munich Germany, Medical Oncological Research
